前交叉韧带重建患者的围手术期阿片类药物咨询:一项随机对照试验
这项在单中心开展的平行组随机对照试验纳入121例≥14岁前交叉韧带重建患者,比较限制阿片类药物围手术期疼痛管理教育与咨询(治疗组)和传统疼痛管理(对照组)对术后3个月总吗啡当量消耗的影响。治疗组平均消耗46.0 mg,对照组63.6 mg(p < 0.001),而术后14天疼痛评分两组无显著差异(p = 0.82)。作者认为这种易于实施的方法可减少阿片类药物使用而不增加术后疼痛。
要点
- 限制阿片类药物的围手术期教育咨询使术后3个月总吗啡当量消耗从63.6 mg降至46.0 mg(p < 0.001)。
- 术后14天疼痛数字评分治疗组2.5 vs 对照组2.4(p = 0.82),两组无显著差异。
- 术后3个月羟考酮处方续配治疗组4例(6.7%)vs 对照组6例(9.8%)(p = 0.53)。
核心结论
- 在接受前交叉韧带重建手术的患者中,限制阿片类药物的疼痛管理教育与咨询减少了阿片类药物消耗,未观察到术后疼痛增加。
- 作者认为临床医生应考虑这种易于实施的方法以减少接受该常见手术患者的阿片类药物使用。
研究设计与样本
- 平行组随机对照试验,在单一学术机构开展,纳入≥14岁接受前交叉韧带重建手术的患者。
- 排除翻修前交叉韧带手术、开放软骨手术、有海洛因使用史或需治疗的阿片类药物使用史的患者。
- 计算机系统按1:1比例随机分配至治疗组(限制阿片类药物的围手术期疼痛管理教育与咨询,指示仅作为最后手段使用阿片类药物)或对照组(传统围手术期疼痛管理,指示按需使用阿片类药物以「抢先控制疼痛」)。
- 共入组121例患者,平均年龄29岁(标准差12),男性67例(55%);35例非裔美国人、10例亚裔、69例白人、7例其他。
- 主要结局为术后3个月消耗的总吗啡当量;次要结局包括数字评分量表疼痛、睡眠质量、阿片类药物处方续配和患者满意度。
主要发现
- 术后3个月内,治疗组60例患者平均消耗总吗啡当量46.0 mg(标准差126.1),对照组61例患者平均消耗63.6 mg(标准差83.4)(p < 0.001)。
- 术后前14天疼痛数字评分平均值治疗组为2.5(95%CI 2.0至2.9),对照组为2.4(95%CI 1.9至2.9)(p = 0.82)。
- 术后3个月内羟考酮处方续配治疗组4例(6.7%),对照组6例(9.8%)(p = 0.53)。
- 睡眠质量和患者满意度两组相似。
临床怎么用
- 作者认为临床医生应考虑这种易于实施的方法以减少接受前交叉韧带重建手术患者的阿片类药物使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of opioids to manage pain after anterior cruciate ligament (ACL) reconstruction remains problematic. This study evaluated the impact of opioid-limiting perioperative pain management education and counseling on postoperative opioid consumption. METHODS: A parallel-arm, randomized controlled trial was conducted at a single academic institution. We included patients ≥14 years old who underwent ACL reconstruction surgery. Patients undergoing revision ACL surgery or open cartilage procedures, or who had a history of heroin use or opioid use requiring treatment, were excluded. A computer-based system randomly assigned participants in a 1:1 ratio to receive opioid-limiting perioperative pain management education and counseling with instructions to take opioids only as a last resort (treatment group) or traditional perioperative pain management with instructions to take opioids as needed for severe pain to "stay ahead of the pain" (control group). The primary outcome was the total morphine equivalents (TMEs) consumed in the 3 months after surgery. Secondary outcomes included pain measured with the Numeric Rating Scale, sleep quality, opioid prescription refills, and patient satisfaction. RESULTS: The trial enrolled 121 patients, with a mean age (and standard deviation [SD]) of 29 (12) years (67 [55%] male; 35 African American, 10 Asian, 69 White, and 7 other). Within 3 months after surgery, 60 patients assigned to the treatment group consumed a mean of 46.0 mg of TMEs (SD, 126.1) and 61 patients assigned to the control group consumed 63.6 mg of TMEs (SD, 83.4; p < 0.001). The average score on the Numeric Rating Scale for pain in the first 14 days was 2.5 (95% confidence interval [CI], 2.0 to 2.9) in the treatment group and 2.4 (95% CI, 1.9 to 2.9) in the control group (p = 0.82). Four patients (6.7%) in the treatment group and 6 patients (9.8%) in the control group refilled their oxycodone prescriptions within 3 months after surgery (p = 0.53). Sleep quality and patient satisfaction were similar between groups. CONCLUSIONS: Among patients undergoing ACL reconstruction surgery, opioid-limiting pain management education and counseling reduced opioid consumption with no observed increase in postoperative pain. Clinicians should consider this easily implementable approach to reduce opioid use among patients undergoing this common procedure. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
引用
- Packer JD, Aneizi A, Honig EL, et al. Perioperative Opioid Counseling for Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial. J Bone Joint Surg Am. 2025. PMID: 40440513. doi:10.2106/JBJS.24.00822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。